IP Verse

Pies competitive analysis

Latest oppositions filed by Pies

Explore patent oppositions filed by Pies against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3853305
High-Purity Peg Lipids And Uses ThereofMODERNAJun 27, 2025
EP3283059
Method For Producing Rna CompositionsCUREVACOct 3, 2024
EP3558896
Mixture Of Aryl Substituted (Thio)Phosphoric Acid Triamide Urease Inhibitors With Phosphorus-Containing Urea FertilizersBASFMay 16, 2023
EP3590949
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNAFeb 20, 2023
EP2791160
Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNADec 2, 2022
EP3590949
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNASep 23, 2022
EP3682905
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 31, 2022
EP3497104
Solid State Forms Of Lumateperone Ditosylate SaltASSIA CHEMICAL INDUSTRIESJun 30, 2022
EP3170842
Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use ThereofCAFA THERAPEUTICSJun 4, 2020
EP3173092
Rna Containing Composition For Treatment Of Tumor DiseasesCUREVACMar 26, 2020

Latest patents of Pies opposed by its competitors

Explore Pies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3626898
Dec 9, 2020Profile Pipe System1

Latest PTAB cases involving Pies

Discover the latest PTAB cases involving Pies, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pies with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SHIRE HUMAN GENETIC THERAPIES315 - 1
CHUGAI SEIYAKU KABUSHIKI KAISHA3117 - 1
GREEN CROSS CORPORATION211 -
WITHERS & ROGERS37 - - -